arrow
T

Thomas Wısnıewskı

NYU Grossman School of Medicine
H指数:92
被引数:3.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Disruption of hippocampal upstream regulators of mTOR and insulin pathways in Down syndrome with Alzheimer's disease neuropathology: Preliminary observations

唐氏综合征合并阿尔茨海默病神经病理中海马上游调控因子对mTOR和胰岛素通路的破坏:初步观察

2026-08-240
OA
Proteomic comparison of hippocampal neurofibrillary tangles in PART, intermediate Alzheimer’s disease and advanced Alzheimer’s disease

海马神经原纤维缠结在原发性年龄相关性tau蛋白病、中期阿尔茨海默病和晚期阿尔茨海默病中的蛋白质组学比较

2026-08-010
OA
Association of plasma biomarkers with amyloid and tau PET in pre-dementia stages

血浆生物标志物与痴呆前阶段淀粉样蛋白和tau蛋白PET成像的关联

2026-05-050
OAAI
The Neighborhoods Study: Examining the social exposome in Alzheimer's disease and related dementias

邻里研究:考察阿尔茨海默病及相关痴呆症的社会暴露组

2025-11-130
OAAI
Celebrating neuropathology's contributions to Alzheimer's Disease Research Centers

庆祝神经病理学对阿尔茨海默病研究中心的贡献

2025-10-140
OAAI
Body mass index and blood volume influence plasma biomarkers and positron emission tomography classification in preclinical Alzheimer's disease

体重指数和血容量影响血浆生物标志物和正电子发射断层扫描分类,在阿尔茨海默病前临床阶段。

2025-10-110
OAAI
Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s disease
2025-07-010
OAAI
SARS-CoV-2 infection of human cortical cells is influenced by the interaction between aneuploidy and biological sex: insights from a Down syndrome in vitro model

SARS-CoV-2感染人皮质细胞受非整倍性与生物性别相互作用的影响:来自唐氏综合征体外模型的见解

2025-05-300
OAAI
Nerve growth factor precursor alterations in neuron-derived extracellular vesicles from individuals with Down syndrome along the Alzheimer's disease continuum

唐氏综合征个体中,源自神经元的外泌体中神经生长因子前体改变,沿着阿尔茨海默病连续谱。

2025-04-210
OAAI